StemXcell™ Activated MSCs
Acute Liver Disease (NAFLD/NASH/Cirrhosis)
Pre-clinicalActive
Key Facts
About PrimeGen US
PrimeGen US is a private, pre-clinical stage biotech founded in 2005 and headquartered in Irvine, California. The company is developing activated mesenchymal stem cell (MSC) therapies using its patented StemXcell™ platform, which pre-programs MSCs to counteract inflammation. Its lead programs target inflammatory liver diseases, with preparations underway for FDA-authorized clinical trials. The company operates as a therapeutics developer and is currently pre-revenue.
View full company profile